Fermér C - Search Results

1

TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.

Paus E, Haugen MH, Olsen KH, Flatmark K, Maelandsmo GM, Nilsson O, Röijer E, Lundin M, Fermér C, Samsonova M, Lebedin Y, Stigbrand T. Paus E, et al. Among authors: fermer c. Tumour Biol. 2011 Feb;32(1):1-12. doi: 10.1007/s13277-010-0073-1. Epub 2010 Jul 24. Tumour Biol. 2011. PMID: 20652782

2

Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP.

Nordlund MS, Fermer C, Nilsson O, Warren DJ, Paus E. Nordlund MS, et al. Among authors: fermer c. Tumour Biol. 2007;28(2):100-10. doi: 10.1159/000099335. Epub 2007 Feb 7. Tumour Biol. 2007. PMID: 17287611

3

Specificity rescue and affinity maturation of a low-affinity IgM antibody against pro-gastrin-releasing peptide using phage display and DNA shuffling.

Fermér C, Andersson I, Nilsson K, Nilsson O. Fermér C, et al. Tumour Biol. 2004 Jan-Apr;25(1-2):7-13. doi: 10.1159/000077717. Tumour Biol. 2004. PMID: 15192306

4

Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies.

Lidqvist M, Nilsson O, Holmgren J, Hall C, Fermér C. Lidqvist M, et al. Among authors: fermer c. J Immunol Methods. 2008 Sep 15;337(2):88-96. doi: 10.1016/j.jim.2008.06.002. Epub 2008 Jul 9. J Immunol Methods. 2008. PMID: 18606164

5

Detection of human papillomavirus oncoprotein E7 in liquid-based cytology.

Lidqvist M, Nilsson O, Holmgren J, Hölters S, Röijer E, Dürst M, Fermér C. Lidqvist M, et al. Among authors: fermer c. J Gen Virol. 2012 Feb;93(Pt 2):356-363. doi: 10.1099/vir.0.034884-0. Epub 2011 Oct 19. J Gen Virol. 2012. PMID: 22012460

6

Lab-on-chip for the isolation and characterization of circulating tumor cells.

Roeser T, Ritzi M, Drese KS, Laureyn W, Liu C, O'Sullivan CK, Ozalp VC, Fermer C, Nilsson O, Hauch S, Albert W, Borgen E, Nygre AO. Roeser T, et al. Among authors: fermer c. Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:6447-9. doi: 10.1109/IEMBS.2007.4353833. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18003499 No abstract available.

7

A comparative study of two PODXL antibodies in 840 colorectal cancer patients.

Kaprio T, Hagström J, Fermér C, Mustonen H, Böckelman C, Nilsson O, Haglund C. Kaprio T, et al. Among authors: fermer c. BMC Cancer. 2014 Jul 8;14:494. doi: 10.1186/1471-2407-14-494. BMC Cancer. 2014. PMID: 25004935 Free PMC article.

8

A novel stem cell associated marker identified by monoclonal antibody HESC5:3 differentiates between neoplastic lesions in follicular thyroid neoplasms.

Heikkilä A, Fermér C, Hagström J, Louhimo J, Mäenpää H, Siironen P, Heiskanen I, Nilsson O, Arola J, Haglund C. Heikkilä A, et al. Among authors: fermer c. APMIS. 2015 Jul;123(7):604-12. doi: 10.1111/apm.12393. Epub 2015 May 9. APMIS. 2015. PMID: 25960045

9

Podocalyxin as a Prognostic Marker in Gastric Cancer.

Laitinen A, Böckelman C, Hagström J, Kokkola A, Fermér C, Nilsson O, Haglund C. Laitinen A, et al. Among authors: fermer c. PLoS One. 2015 Dec 16;10(12):e0145079. doi: 10.1371/journal.pone.0145079. eCollection 2015. PLoS One. 2015. PMID: 26674770 Free PMC article.

10

Podocalyxin is a marker of poor prognosis in colorectal cancer.

Kaprio T, Fermér C, Hagström J, Mustonen H, Böckelman C, Nilsson O, Haglund C. Kaprio T, et al. Among authors: fermer c. BMC Cancer. 2014 Jul 8;14:493. doi: 10.1186/1471-2407-14-493. BMC Cancer. 2014. PMID: 25004863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page